44 results
8-K
EX-2.1
QLGN
Qualigen Therapeutics Inc
26 Jul 23
Entry into a Material Definitive Agreement
5:25pm
. § 1320a–7h), and (x) Medicare (Title XVIII of the Social Security Act).
“Income Tax Liability Amount” means an amount, which shall not be less than … in Software and other works of authorship and moral rights) (collectively, “Copyrights”); (d) internet domain names and social media accounts or user names
424B5
QLGN
Qualigen Therapeutics Inc
1 Dec 21
Prospectus supplement for primary offering
2:28pm
care systems, personnel availability, supply chains, social and political assumptions, and capital markets. Those impacts are expected to be especially … , social engineering and other means to affect service reliability and threaten the confidentiality, integrity and availability of information), which may
10-KT
EX-4.14
jf6f53jeci w9h
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
5tqzjyqwq6h3zqwdnh8
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
EX-4.13
c74vh9
31 Mar 21
Annual report (with FYE transition)
4:33pm
424B5
hxmdasei
18 Dec 20
Prospectus supplement for primary offering
1:26pm
S-8
EX-4.8
4q5y1
2 Oct 20
Registration of securities for employees
4:54pm
424B5
dx5lw3yps6ot7f 8t
2 Oct 20
Prospectus supplement for primary offering
4:24pm
424B5
uvv1o9dd
4 Aug 20
Prospectus supplement for primary offering
6:16am
424B5
kiaktnu6 lh33l7
10 Jul 20
Prospectus supplement for primary offering
2:35pm
8-K
EX-10.1
i9irn9v 8v5514g
11 Jun 20
Departure of Directors or Certain Officers
12:32pm
8-K
EX-10.15
ftq6tv47ggsfyuy91
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.17
gcu4plgyzm
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
jmd7dd
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.16
fraef409 v1gs
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.18
bem0h ke10mzb
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm